Aadit Shah

Aadit joined +ND Capital as a Venture Fellow in 2021 with a particular interest in genetic medicines and immunotherapies. He is currently an MD candidate at Stanford with a BS in Biomedical Engineering from Washington University and an MPhil in Bioscience Enterprise from the University of Cambridge.

Prior to Stanford and +ND, he conducted 4+ years in immunology/infectious diseases as well as spearheading the development of medical devices and digital health tools through to acquisition. Aadit also has experience in the business of biotechnology with previous BD/CD roles in the UK and in Boston as part of the Flagship ecosystem.